Leah Tate Form 4 BELDEN / Leah Tate ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Tate Leah

(Last) (First) (Middle)

C/O BELDEN INC.

1 N. BRENTWOOD BLVD., 15TH FLOOR

(Street)

ST. LOUIS MO 63105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BELDEN INC. [ BDC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
SVP - HR

3. Date of Earliest Transaction (Month/Day/Year)
11/01/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/01/2024		M		1,163	A	$61.79	24,406	D
Common Stock	11/01/2024		D		777(1)	D	$115.887	23,629	D
Common Stock	11/01/2024		M		1,528	A	$51.14	25,157	D
Common Stock	11/01/2024		D		920(3)	D	$115.887	24,237	D
Common Stock	11/01/2024		M		1,748	A	$45.11	25,985	D
Common Stock	11/01/2024		D		987(4)	D	$115.887	24,998	D
Common Stock	11/01/2024		M		884	A	$53.79	25,882	D
Common Stock	11/01/2024		D		547(5)	D	$115.887	25,335	D
Common Stock	11/01/2024		M		1,667	A	$85.77	27,002	D
Common Stock	11/01/2024		D		1,359(6)	D	$115.887	25,643	D
Common Stock								3,360	I	By Spouse
Common Stock								1,013.8004(2)	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Rights	$61.79	11/01/2024		M			1,163	02/28/2020(7)	02/28/2029	Common Stock	1,163	$0	0	D
Stock Appreciation Rights	$51.14	11/01/2024		M			1,528	02/11/2021(7)	02/11/2030	Common Stock	1,528	$0	0	D
Stock Appreciation Rights	$45.11	11/01/2024		M			1,748	02/16/2022(7)	02/16/2031	Common Stock	1,748	$0	0	D
Stock Appreciation Rights	$53.79	11/01/2024		M			884	02/22/2023(7)	02/22/2032	Common Stock	884	$0	441	D
Stock Appreciation Rights	$85.77	11/01/2024		M			1,667	03/07/2024(7)	03/07/2033	Common Stock	1,667	$0	3,333	D

Explanation of Responses:

1. This represents the difference between the number of SARs exercised (1,163) and the number of shares issued as a result of the exercise (386). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($115.887) and the exercise price ($61.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations.

2. Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.

3. This represents the difference between the number of SARs exercised (1,528) and the number of shares issued as a result of the exercise (608). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($115.887) and the exercise price ($51.14). Additional shares were then withheld to satisfy the Company's tax withholding obligations.

4. This represents the difference between the number of SARs exercised (1,748) and the number of shares issued as a result of the exercise (761). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($115.887) and the exercise price ($45.11). Additional shares were then withheld to satisfy the Company's tax withholding obligations.

5. This represents the difference between the number of SARs exercised (884) and the number of shares issued as a result of the exercise (337). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($115.887) and the exercise price ($53.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations.

6. This represents the difference between the number of SARs exercised (1,667) and the number of shares issued as a result of the exercise (308). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($115.887) and the exercise price ($85.77). Additional shares were then withheld to satisfy the Company's tax withholding obligations.

7. The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date.

	/s/ Brian E. Anderson, attorney-in-fact for Leah Tate	11/05/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.